PLRX Q2 2025 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$447,000

Operating Income

-$46M

Net Income

-$43M

EPS (Diluted)

$-0.71

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$300M

Total Liabilities

$80M

Stockholders' Equity

$220M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$447,000	-$622,000	+28.1%
Operating Income	-$46M	-$61M	+24.8%
Net Income	-$43M	-$56M	+22.5%